Dogs Segment, by Companion Animal to Account Largest Share in Companion Animal Diagnostics Market during 2025-2031

According to our new research study on "Companion Animal Diagnostics Market Forecast to 2031 - Global Analysis - by Product, Companion Animal, Technology, Application, End User, and Geography," the market was valued at US$ 4.61 billion in 2024 and is projected to reach US$ 8.80 billion by 2031; it is expected to register a CAGR of 9.8% during 2025-2031. The upsurging companion animal healthcare expenditure and the growing pet humanization and ownership contribute to the increasing companion animal diagnostics market size. However, the high cost of diagnostic products and infrastructure hampers the companion animal diagnostics market growth. Further, integrating digitalization and artificial intelligence in veterinary healthcare is expected to bring new companion animal diagnostics market trends in the coming years.

Companion Animal Diagnostics Market Analysis

The humanization of pets is growing, and the global population is reshaping the veterinary healthcare landscape. Pet owners are increasingly willing to pay for their pets' health, boosting the demand for accurate and minimally invasive diagnostic solutions.

Companion animals are highly prone to infectious and chronic diseases. Several references highlight the growing adoption of dogs and their related expenditure on healthcare services. The pet industry is comprehensive, and the demand for companion animal diagnostic products will increase during the forecast period. According to the American Pet Products Association's 2023-2024 National Pet Owners Survey, in 2023, over 46.5 million and 65.1 million households in the US owned cats and dogs, respectively. According to HealthforAnimals' report, over two million people adopted pets during the UK's pandemic lockdowns, while in Australia, over a million pets were adopted during the pandemic. Moreover, the US, EU, and China families have adopted over half a billion dogs and cats. Dogs are the most popular pets in around one in three homes. Nearly a quarter of pet owners have a cat. Increasing demographic changes, rising income levels, and growing preferences post-pandemic have increased the number of people adopting pets. Pet owners in well-developed economies seek protection against the escalating veterinary treatment costs by applying for a pet insurance policy. In countries such as Sweden and the UK, the penetration rate of pets in households is very high, usually at a rate that covers significant numbers of pets under insurance plans.

Companion Animal Diagnostics Market Report Scope

The companion animal diagnostics market analysis has been carried out by considering the following segments: product, companion animal, technology, application, end user, and geography.

Based on product, the companion animal diagnostics market is segmented into consumables and instruments. The consumables segment held the largest companion animal diagnostics market share in 2024. Several diagnostic instruments need substantial upfront investment and maintenance; however, consumables offer a more affordable solution for veterinary clinics. These products contain test strips, slides, reagents, and ready-to-use kits that simplify complex diagnostic processes, allowing veterinarians to detect common diseases and monitor animal health. For instance, rapid antigen test kits for canine parvovirus or feline leukemia virus deliver results within minutes, facilitating timely treatment decisions and improving animal outcomes without requiring specialized equipment or extensive training. Consumables and reagents offer more flexibility and convenience than standalone diagnostic instruments. They can be readily transported, stocked, and utilized in mobile or remote veterinary services. Pet owners seek more accessible healthcare for their companion animals. These products can be tailored for precise diagnostic needs, assuring higher sensitivity and specificity for diseases or conditions common in pets. This adaptability, integrated with their cost-effectiveness and ease of use, makes consumables the preferred choice for many veterinarians.

Based on companion animal, the companion animal diagnostics market is segmented into dogs, cats, horses, and others. The dogs segment held the largest companion animal diagnostics market share in 2024. The prevalence of obesity, zoonotic diseases, cancer, and skin disorders is growing significantly in dogs. Moreover, the pet ownership and the number of companion animals in developed nations are rising. Dogs are more reliable than other companion animals, and the cost associated with veterinary care for dogs tends to be comparatively higher than for cats. The American Veterinary Medical Association declares that around one in four dogs develop neoplasia, and nearly half of dogs aged over ten have cancer. The incidence highlights the critical role of diagnostic services in effective canine health management. The adoption of dogs as companion animals has accelerated. As dogs are increasingly seen as part of the family, pet owners are becoming more attentive to their health needs. This change has led to an enhanced demand for advanced veterinary healthcare services. Pet owners are more likely to fund sophisticated health monitoring and diagnostic solutions to guarantee their pets' well-being.

Based on technology, the companion animal diagnostics market is segmented into immunodiagnostics, molecular diagnostics, clinical biochemistry, hematology, urinalysis, and others. The immunodiagnostics segment held the largest companion animal diagnostics market share in 2024. Immunoassays are biochemical tests that use antigen-antibody binding reactions to detect the presence of specific molecules in the sample. The applications of immunoassay in veterinary science are vast. The immunodiagnostics include lateral flow assays, ELISA tests, allergen-specific immunodiagnostic tests, and immunoassay analyzers. Owing to the high specificity and sensitivity, these tests are anticipated to grow during the forecast period. Immunodiagnostic tests are a practical and widely used tool for analyzing animal diseases due to their expanding application areas, such as detecting arboviral disease.

An increase in multiple zoonoses, including bovine ephemeral fever, leptospirosis, Johne's diseases, viral respiratory tract infections, dermatophyte fungi, and infectious bovine rhinotracheitis, in companion animals is enabling the use of immunodiagnostics technologies, due to their high throughput capability, simplicity, time & cost-efficiency, field portability, and others. The increasing prevalence of companion animals and the rising demand for cutting-edge diagnostic tools drive the demand for immunodiagnostics.

In terms of application, the companion animal diagnostics market is segmented into clinical pathology, bacteriology, parasitology, virology, and others. The clinical pathology segment dominated the market in 2024. The demand for complete pet insurance is increasing. This trend has spurred greater investment in diagnostic services to support early disease diagnosis and effective treatment. Clinical pathology tests are cost-effective and highly accessible.

Companion animals such as cats and dogs often suffer from chronic conditions such as diabetes and kidney disorders. This has led owners to depend more on clinical pathology for accurate diagnosis and management. Moreover, the incidence of chronic diseases such as rabies virus, skin disease is rising globally. The expanding veterinary healthcare sector and a rising number of veterinary professionals are driving the demand for clinical pathology labs and test kits. This method is used to identify infections, inflammatory conditions, and various cancers in animals through minimally invasive procedures such as fine needle aspiration. For instance, veterinarians often use clinical pathology to examine skin lumps or lymph node swellings in dogs and cats to determine if they are benign or malignant. The increasing demand for minimally invasive diagnostic methods is boosting the companion animal diagnostics market growth.

In terms of end user, the companion animal diagnostics market is segmented into diagnostic and reference laboratories, veterinary hospitals and clinics, research institutes, and others. The veterinary hospitals and clinics segment dominated the market in 2024. The rising adoption of technological innovations such as point-of-care diagnostics (POCD) enables faster, more accurate testing. These advancements allow for quicker detection and treatment of diseases, improving overall veterinary care. For instance, Symmetrical Dimethylarginine (SDMA) test kits enhanced by artificial intelligence (AI) assess kidney function in dogs and cats. These technologies significantly enhance diagnostic capabilities in veterinary practices.

The awareness of zoonotic diseases, which can be transmitted between animals and humans, is increasing. As the threat of these diseases becomes more recognized, there is a growing need for reliable tests to detect and manage infections. Veterinary hospitals and clinics safeguard animal and human health by providing early detection and treatment. This growing awareness has expanded the market for diagnostic services, especially for zoonotic disease management.

ARI Medical Technology Co., Ltd., Innovative Diagnostics SAS, Tianjin LOCMEDT Technologies Co., Ltd, Zoetis Inc., Demeditec Diagnostics GmbH, Idexx Laboratories, i-SENS Inc., Elabscience Biotechnology Inc., Universal Biosensors Inc., and Immunology Consultants Laboratory Inc. are among the leading companies operating in the global companion animal diagnostics market.

Companies operating in the companion animal diagnostics market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies in the companion animal diagnostics market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall companion animal diagnostics market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

Contact Us
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com